Screening compound: VGGRRBVIGYUCGR-UHFFFAOYSA-N

Screening compound: VGGRRBVIGYUCGR-UHFFFAOYSA-N
Screening compound: VGGRRBVIGYUCGR-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
VGGRRBVIGYUCGR-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S050-0207

Molecular Formula

C25H21N3O4 (C25 H21 N3 O4)

Compound Name

5-(4-{[1-(3-methoxybenzoyl)azetidin-3-yl]oxy}phenyl)-3-phenyl-1,2,4-oxadiazole

IUPAC name

5-(4-{[1-(3-methoxybenzoyl)azetidin-3-yl]oxy}phenyl)-3-phenyl-124-oxadiazole

SMILES

COc1cccc(C(N(C2)CC2Oc(cc2)ccc2-c2nc(-c3ccccc3)no2)=O)c1

InChI

InChI=1S/C25H21N3O4/c1-30-21-9-5-8-19(14-21)25(29)28-15-22(16-28)31-20-12-10-18(11-13-20)24-26-23(27-32-24)17-6-3-2-4-7-17/h2-14,22H,15-16H2,1H3

InChI Key

VGGRRBVIGYUCGR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29007985

VGGRRBVIGYUCGR-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

KRAS-Targeted Library (16000 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

Peptidomimetic Library (37031 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with VGGRRBVIGYUCGR-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound VGGRRBVIGYUCGR-UHFFFAOYSA-N?
Check Price and Availability of VGGRRBVIGYUCGR-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of VGGRRBVIGYUCGR-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for VGGRRBVIGYUCGR-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for VGGRRBVIGYUCGR-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of VGGRRBVIGYUCGR-UHFFFAOYSA-N available by request